Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1990 2
1992 2
1993 3
1994 3
1995 3
1996 3
1997 7
1998 3
1999 10
2000 7
2001 6
2002 6
2003 4
2004 3
2005 2
2006 1
2007 1
2012 2
2013 2
2014 1
2015 4
2016 2
2017 1
2018 2
2019 1
2021 3
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Targeting adenovirus.
Wickham TJ. Wickham TJ. Gene Ther. 2000 Jan;7(2):110-4. doi: 10.1038/sj.gt.3301115. Gene Ther. 2000. PMID: 10673715 Review.
GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes.
Uenishi GI, Repic M, Yam JY, Landuyt A, Saikumar-Lakshmi P, Guo T, Zarin P, Sassone-Corsi M, Chicoine A, Kellogg H, Hunt M, Drow T, Tewari R, Cook PJ, Yang SJ, Cerosaletti K, Schweinoch D, Guiastrennec B, James E, Patel C, Chen TF, Buckner JH, Rawlings DJ, Wickham TJ, Mueller KT. Uenishi GI, et al. Among authors: wickham tj. JCI Insight. 2024 Feb 8;9(6):e171844. doi: 10.1172/jci.insight.171844. JCI Insight. 2024. PMID: 38516892 Free PMC article.
Adenoviral vectors for gene transfer.
Kovesdi I, Brough DE, Bruder JT, Wickham TJ. Kovesdi I, et al. Among authors: wickham tj. Curr Opin Biotechnol. 1997 Oct;8(5):583-9. doi: 10.1016/s0958-1669(97)80033-x. Curr Opin Biotechnol. 1997. PMID: 9353227 Review.
Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic.
Zhang X, Luo M, Dastagir SR, Nixon M, Khamhoung A, Schmidt A, Lee A, Subbiah N, McLaughlin DC, Moore CL, Gribble M, Bayhi N, Amin V, Pepi R, Pawar S, Lyford TJ, Soman V, Mellen J, Carpenter CL, Turka LA, Wickham TJ, Chen TF. Zhang X, et al. Among authors: wickham tj. Nat Commun. 2021 May 11;12(1):2637. doi: 10.1038/s41467-021-22898-3. Nat Commun. 2021. PMID: 33976146 Free PMC article.
Adenovirus as a gene therapy vector for hematopoietic cells.
Marini FC 3rd, Yu Q, Wickham T, Kovesdi I, Andreeff M. Marini FC 3rd, et al. Among authors: wickham t. Cancer Gene Ther. 2000 Jun;7(6):816-25. doi: 10.1038/sj.cgt.7700174. Cancer Gene Ther. 2000. PMID: 10880011 Review.
Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15.
McArdel SL, Dugast AS, Hoover ME, Bollampalli A, Hong E, Castano Z, Leonard SC, Pawar S, Mellen J, Muriuki K, McLaughlin DC, Bayhi N, Carpenter CL, Turka LA, Wickham TJ, Elloul S. McArdel SL, et al. Among authors: wickham tj. Cancer Immunol Immunother. 2021 Sep;70(9):2701-2719. doi: 10.1007/s00262-021-03001-7. Epub 2021 Jul 9. Cancer Immunol Immunother. 2021. PMID: 34244816 Free PMC article.
Nanoliposome targeting in breast cancer is influenced by the tumor microenvironment.
Dumont N, Merrigan S, Turpin J, Lavoie C, Papavasiliou V, Geretti E, Espelin CW, Luus L, Kamoun WS, Ghasemi O, Sahagian GG, Muller WJ, Hendriks BS, Wickham TJ, Drummond DC. Dumont N, et al. Among authors: wickham tj. Nanomedicine. 2019 Apr;17:71-81. doi: 10.1016/j.nano.2018.12.010. Epub 2019 Jan 14. Nanomedicine. 2019. PMID: 30654182
85 results